Business Wire

Lyten Acquires Europe’s Largest Battery Energy Storage Systems Manufacturing Operation from Northvolt

1.7.2025 09:00:00 CEST | Business Wire | Press Release

Share

Lyten, the supermaterial applications company and global leader in lithium-sulfur batteries, announced today the acquisition of Northvolt’s Dwa ESS operations in Gdansk, Poland, a 25,000 square meter (270,000 sq ft) battery energy storage systems (BESS) manufacturing and R&D facility. Northvolt Dwa ESS is the largest BESS manufacturing facility in Europe and was part of Northvolt Systems. The financial terms of the acquisition are not being released by either party.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250701098618/en/

Aerial view of the 25,000-square meter battery energy storage systems manufacturing facility, in Gdansk, Poland, acquired by Lyten from Northvolt. The facility, previously known as Northvolt Dwa ESS, is Europe’s largest energy storage systems manufacturing operation.

The Northvolt acquisition accelerates expansion of Lyten’s lithium-sulfur batteries into Europe and provides Lyten with production capacity to meet demand in the growing BESS market. Lyten has previously announced its lithium-sulfur batteries are shipping commercially for drones, launching onto the International Space Station, and selected by Chrysler, a Stellantis company, for its Halcyon Concept Electric Vehicle.

Lyten Lithium-Sulfur batteries have unique characteristics that make them ideally suited to meet rapidly growing demand for BESS: a broader operating temperature range especially in hot conditions, improved safety, and the ability to be made from abundantly available, low-cost materials found throughout the US and Europe. Lithium-Sulfur is also a high energy density, ultra-lightweight battery.

“Northvolt’s BESS manufacturing operations are truly world class and are a seamless strategic fit for Lyten as we launch an exciting new chapter for our company. We plan to immediately restart operations in Poland and deliver on existing and new customer orders,” said Dan Cook, Lyten CEO & Co-Founder. “The Port of Gdansk, local and federal officials have all been fully supportive as we combine Silicon Valley technology with Polish engineering and operations talent to export next generation energy storage technology to customers worldwide.”

The Dwa ESS facility came online in 2023. The facility includes equipment to ramp up to 6 GWh of energy storage manufacturing capacity and the footprint to expand to 10+ GWh in the future. The facility is supplied by renewable power and has contracted orders extending into 2026.

“The message we are hearing clearly from European customers is that they want energy storage systems manufactured in Europe using locally sourced supply chains free of geopolitical risk. Gdansk, Poland is the perfect location to meet this need for Europe,” added Lars Herlitz, Lyten Chairman and Co-Founder.

BESS is the fastest growing segment of the battery market, as the technology is critical to meet AI data center power demand, provide resiliency to the electricity grid in Europe and North America, and meet surging power demand in emerging markets. In December, Lyten announced a $650M LOI from the Export Import Bank of the US (EXIM) to expand battery manufacturing and commence delivery of BESS to Emerging Market nations.

Robert Chryc-Gawrychowski, CEO of Northvolt Poland, stated, “Northvolt set out to lead the sustainable development of Europe’s battery industry. Lyten is carrying that mission forward with BESS manufacturing and the introduction of lithium-sulfur batteries in Europe, which replaces minerals like nickel, cobalt, manganese, and graphite, with locally abundant battery materials. Moreover, it is important and exciting that the factory in Gdansk, built for the production of energy storage systems, will continue its operations.”

Aleksandra Dulkiewicz, President of Gdansk, stated, "The planned investment is a confirmation of the growing competitiveness of Poland and specifically Gdansk on the global economic map. For Gdansk, Lyten’s activities constitute an opportunity to cooperate in the field of energy storage, create energy innovation centres and advance R&D partnerships with local universities.”

In late 2024 Northvolt announced the intended sale of its Northvolt Systems business unit as part of its strategic review and bankruptcy procedures. Scania, a Swedish commercial vehicle manufacturer, announced the purchase of the Industrial subset of the Northvolt Systems division in April 2025.

Lyten and Northvolt intend to close the transaction in 3Q 2025.

About Lyten

Lyten, founded in 2015, is a supermaterial applications company that has received more than $425 million in equity investment and secured LOIs for $650M in financing from the Export Import Bank of the US. Lyten has built a proprietary materials platform, called Lyten 3D Graphene, that it uses to build better performing, lower cost, and decarbonizing products, including its next generation lithium-sulfur battery. Lyten corporate headquarters is in San Jose, CA and European headquarters is in Luxembourg.

The company lists more than 520 patents granted or pending and is currently manufacturing in San Jose, CA. Lyten recently announced the acquisition of Northvolt’s battery manufacturing plant in San Leandro, California to quickly scale production to meet the demand for American made batteries. In 2024, Lyten announced its integration into Chrysler’s Halcyon Concept electric vehicle, plans to integrate lithium-sulfur into AEVEX Aerospace’s unmanned aerial vehicles, and the selection of Lyten Lithium-Sulfur for demonstration on-orbit aboard the International Space Station (ISS), scheduled for launch later in 2025.

Lyten was named Fast Company’s #8 Most Innovative Energy Company and named one of America’s Top Green Technology Companies by Time in 2024 and one of the World’s Top Green Technology Companies by Time in 2025.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250701098618/en/

Contacts

Bob Zeitlinger
bzeitlinger@makovsky.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press Release

Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press Release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press Release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press Release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press Release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye